Domo Ventures

We're a global leader in premium drinks with over 200 brands sold in nearly 180 countries. Our portfolio includes some of the world's most recognized spirits and beers - Johnnie Walker, Smirnoff, Guinness, Baileys, Captain Morgan, Tanqueray, and many more. While Diageo was founded in 1997 through the merger of Guinness and Grand Metropolitan, our brands have heritage that stretches back centuries, some as far as the 17th century. We operate from 132 sites globally, producing 6.5 billion litres of product each year. What drives us is simple: we want to be the world's best brand builder in premium drinks. This means staying focused on what consumers want, innovating responsibly, and growing our brands while promoting positive drinking. We're also committed to our Spirit of Progress ESG plan - our global programme to create a more inclusive and sustainable world through our operations.

At Ferrero, we believe that bringing joy to people through delicious products is more than a business - it's a family tradition spanning three generations. Our journey began in 1946 when brothers Pietro and Giovanni Ferrero opened a small pastry shop in Alba, Italy. Pietro, known as 'the scientist' for his experimental approach to flavors, and Giovanni, the commercial visionary, built a foundation of innovation and quality that defines us today. Now in our third generation with over 47,000 employees worldwide, we've grown into one of the world's largest sweet-packaged food companies while keeping our family culture at the heart of everything we do. We work collaboratively across borders, with offices and production facilities in over 50 countries, to craft products that celebrate life's special moments. Our culture values passion for quality, research, and innovation - attributes that have helped us create iconic brands like Nutella®, Kinder®, Ferrero Rocher®, and Tic Tac®. We are committed to caring for people and our planet, from responsibly sourcing ingredients like hazelnuts and cocoa to supporting the communities where we operate. At Ferrero, every employee plays a role in maintaining our legacy of excellence while embracing new challenges and opportunities in an evolving global market.

The Exploration Company (TEC) is democratizing access to space by building Nyx, a modular, reusable, and in-orbit refillable orbital vehicle. Nyx launches from any heavy launcher worldwide to safely and affordably transport cargo to and from space stations in low-Earth orbit and beyond, with future capabilities for crewed missions. The company’s innovative approach combines launch vehicle agnosticism, competitive pricing at €20,000 per kg for LEO missions, and open interfaces that enable both space and non-space companies to leverage their technology for new applications. Founded in 2021 by aerospace veteran Hélène Huby, TEC has rapidly grown into one of Europe’s fastest-growing space companies, raising €196.8 million in funding and securing landmark contracts with ESA, Axiom Space, and Starlab Space. The company achieved a significant milestone with its "Mission Possible" re-entry demonstration flight in June 2025, validating its carbon-based thermal protection system. As the first European company to sign a Space Act Agreement with NASA, TEC is positioned to serve the growing commercial space station market with Nyx Earth missions starting in 2026, followed by Nyx Gateway to the Lunar Gateway and Nyx Moon for lunar surface operations by 2028. With approximately 400 employees across Germany, France, and Italy, The Exploration Company is building a globally cooperative future in space where spacecraft serve as accessible, sustainable logistics platforms for stations and exploration missions alike.

Terumo Blood and Cell Technologies is a global leader in medical technology, specializing in blood component collection, therapeutic apheresis, and cellular therapy technologies that impact patients' lives every second of every day. With more than 8,000 global associates and operations spanning 130+ countries, the company's innovative solutions enable healthcare providers to deliver life-saving treatments worldwide. Their products process blood components safely, treat serious medical conditions through therapeutic plasma exchange, and advance cellular therapy manufacturing - all while maintaining a patient-centered approach that drives measurable results across their core business areas. Headquartered in Lakewood, Colorado, Terumo BCT operates as part of Terumo Corporation (TSE:4543), a Tokyo-based global healthcare leader founded in 1921. The company's commitment extends beyond technology to include partnerships with organizations like The Leukemia & Lymphoma Society, comprehensive blood safety initiatives, and the 'From the Heart' global program designed to educate and empower communities. Through platforms like Quantum Flex Cell Expansion System for CAR-T therapies and Spectra Optia Apheresis System for treating conditions like sickle cell disease, Terumo BCT continues to expand access to critical treatments and shape the future of blood and cell-based therapies.

Adani Group exists to solve India's most critical infrastructure challenges - powering a nation of 1.4 billion people, building the logistics networks that move 40% of India's maritime trade, and delivering green energy at unprecedented scale. Founded in 1988 as a commodity trading business, the conglomerate has evolved into India's largest integrated infrastructure enabler, spanning ports, airports, energy, logistics, and emerging sectors like data centers and green hydrogen. With 11 publicly traded companies and over 48,000 employees, Adani operates at the intersection of national development and sustainable growth. The company's philosophy of "Growth with Goodness" drives every strategic decision - whether developing one of the world's largest renewable energy portfolios targeting 25 GW by 2025, operating India's largest private thermal power generation capacity, or managing airports serving millions of passengers annually. Adani's four investment-grade rated businesses make it India's only Infrastructure Investment Grade issuer, reflecting commitment to building world-class assets benchmarked to global standards while prioritizing climate action, community development, and ESG principles.

In 2000, a father's determination to free his son from the daily burden of multiple insulin injections sparked the creation of Insulet. That deeply personal mission led to a revolutionary idea sketched on a napkin: a tubeless, wearable insulin delivery system. Over the past two decades, that vision has evolved into Omnipod technology that now serves over 600,000 customers across 25 countries. The company has grown from a compassionate idea into a publicly traded innovator (NASDAQ: PODD) with $2.1 billion in revenue, proving that purpose-driven innovation can transform both lives and industries. Today, Insulet stands at the forefront of diabetes management technology, having launched the world's first tubeless automated insulin delivery system controlled by a smartphone. The company's relentless passion extends beyond product development - they advocate tirelessly for their community of "Podders," push for sustainable and responsible growth, and maintain operations spanning North America, Europe, the Middle East, and Asia Pacific. With the Omnipod 5 system now the #1 prescribed automated insulin delivery system in the U.S., Insulet continues to innovate toward their mission of making diabetes a smaller part of life through technology that offers unprecedented simplicity, freedom, and healthier outcomes.